ANRO
COM:ALTONEUROSCIENCE
Alto Neuroscience
- Stock
locale
United Statesmarket
STOCKSindustry
Biopharmaceuticalwebsite
altoneuroscience.comcrunchbase
alto-neurosciencelinkedin
altoneurosciencefounding date
Jan 01, 2019ipo date
Feb 02, 2024
Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company that engages in the psychiatry drug development business. The company develops ALTO-100 for the treatment of patients with major depressive disorder (MDD) and post-traumatic stress disorder; ALTO-300, a small molecule melatonergic agonist and serotonergic antagonist with antidepressant properties to ...Show More